Searched for
SHRIKANT AKOLKAR
Obesity drugs shed niche tag, set to gain more weight in India pharmaIndia's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The ...- Intense Lilly, Novo rivalry throws India weight-loss drug race wide openEli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outre...
- Haryana election results will boost BJP morale in Maharashtra, Congress may lose bargaining edge: AnalystsThe BJP's victory in Haryana is a morale booster and strengthens its position for upcoming seat-sharing talks in Maharashtra. Politicians m...
- Mankind Pharma draws rush of buy calls on 57% jump since IPOInvestors are scrambling to purchase shares in drug and condom maker, Mankind Pharma Ltd., which has had the most analyst coverage of any n...
- From Marathi manoos to macro Hindutva: Raj Thackeray has to seize the moment, say political watchersStressing that Raj Thackeray, 54, is looking to relaunch his party using the Hindutva card after failing to yield electoral success, Sanjay...
- Positive on Sun Pharma numbers, specialty focus: Ashika Stock BrokingIf I adjust the numbers for Taro (a very poor number with 75% decline year on year), then overall the numbers look good to me.
- Dabholkar and Lankesh killings linked: CBI to courtDabholkar, a Pune-based anti-superstition activist, was shot dead while he was on morning walk in August, 2013. Lankesh was shot dead in fr...
- How Wockhardt Chairman Habil Khorakiwala plans to pull the company out of trouble45 years after he made a profound statement about dying only once, the chairman of Wockhardt would like to repeat it to investors, regulato...
- Investors don't care if a business is run by Lalaji or IIM whizkid, only returns matter!Only 13% of family-run businesses survive till third generation and only 4% go beyond the third.
- A falling dollar index likely to boost inflows into indian marketsIt is good news for Indian equities as it indicates bullish views towards emerging markets.
- No rival here can match Hero in dividend payoutHero Moto-Corp declared an interim dividend of Rs 55 per share and final dividend of Rs 30 per share, taking total dividend up to Rs 85 per...
- Eris Lifesciences IPO sails through; oversubscribed 3 timesThe public offer received bids for 1.34 crore shares against the total issue size of 1.59 crore shares.
- Eris Lifesciences IPO subscribed 75% on Day 2The price band for the share sale has been fixed at Rs 600-603.
- Multibagger hunt: 10 stocks that can give 100% return in 3 yearsNearly 60% of BSE500 stocks have more than doubled investor wealth in last four years.
- Watch out! Any of these factors can play party pooper on D-StreetBesides valuation concerns, the domestic market is facing a host of headwinds ahead.
- Maruti Suzuki reports 15.8% rise in Q4 net profit, meets Street estimatesThe company sold a total of 414,439 vehicles in the latest quarter, a growth of 15% from last year. The company’s expenses rose 20.6% to Rs...
- Neil Armstrong strategy to stock investing: First-mover businesses can deliver big gainsTake this! Shares of Eicher Motors, which enjoy a competitive advantage with its Bullet range of motorbikes, have surged over 7,721% in las...
- Fast & furious: Over 15 smallcap stocks gave up to 100% return in just 28 daysLT Foods more than doubled investor wealth so far in 2017, while shares of Arshiya, National Fertilizers and Unitech rose over 50% each in ...
Load More
